Shandong Xinhua Pharmaceutical Company Limited (HKG: 0719)

Shandong Xinhua Pharmaceutical Company Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 6, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	8,731	11,897	17,740	6,846	5,447	4,336
Market Cap Growth	-30.04%	-32.94%	159.14%	25.67%	25.64%	27.25%
Enterprise Value	9,404	12,706	17,708	8,175	6,459	5,408
Last Close Price	5.24	5.46	7.41	4.12	3.01	3.14
PE Ratio	6.83	6.88	10.74	6.04	4.87	5.85
PS Ratio	0.41	1.33	2.09	0.85	0.76	0.69
PB Ratio	0.71	2.26	3.61	1.53	1.35	1.25
P/FCF Ratio	164.99	-180.42	30.56	563.90	32.76	-212.48
P/OCF Ratio	24.91	40.71	20.70	21.52	10.92	11.13
EV/Sales Ratio	1.07	1.42	2.09	1.02	0.91	0.86
EV/EBITDA Ratio	8.12	11.27	16.45	7.93	6.45	6.59
EV/EBIT Ratio	15.98	22.52	33.62	16.50	11.85	12.39
EV/FCF Ratio	433.93	-192.69	30.51	673.39	38.85	-265.05
Debt / Equity Ratio	0.28	0.28	0.32	0.45	0.49	0.49
Debt / EBITDA Ratio	1.30	1.32	1.45	1.95	1.95	2.08
Debt / FCF Ratio	69.53	-22.70	2.70	166.46	11.75	-83.87
Asset Turnover	0.97	0.98	0.96	0.91	0.89	0.91
Inventory Turnover	5.45	4.58	4.92	4.48	3.76	3.64
Quick Ratio	0.89	0.76	0.68	0.65	0.59	0.47
Current Ratio	1.39	1.33	1.09	1.10	1.13	0.98
Return on Equity (ROE)	10.57%	11.09%	10.65%	10.28%	10.68%	10.91%
Return on Assets (ROA)	4.07%	3.87%	3.73%	3.50%	4.24%	3.94%
Return on Capital (ROIC)	5.58%	5.39%	5.28%	4.88%	5.93%	5.49%
Earnings Yield	14.64%	4.60%	2.62%	6.25%	7.08%	7.74%
FCF Yield	0.61%	-0.55%	3.27%	0.18%	3.05%	-0.47%
Dividend Yield	5.18%	5.05%	3.05%	4.47%	5.92%	4.28%
Payout Ratio	34.81%	35.43%	39.66%	42.59%	39.05%	38.80%
Buyback Yield / Dilution	-0.43%	-3.20%	-6.92%	0.02%	-0.86%	0.14%
Total Shareholder Return	4.75%	1.85%	-3.87%	4.48%	5.06%	4.41%

Source: S&P Capital IQ. Standard template. Financial Sources.